FDA Inspection 713382 — RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank

RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank — FEI 2270850

The FDA completed an inspection of RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank on Mar 21, 2011 in Newark, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 21, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, NJ (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
442521 CFR 606.60(a)Equipment observed, standardized, calibrated
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.